Study design and participants
polycystic ovarian syndrome, diabetes
DIABETES MELLITUS, POLYCYSTIC OVARIAN SYNDROME, PANCREATITIS, DIABETES
A single-blind randomized clinical trial was conducted, enrolling patients aged 40 to 60 years to investigate the impact of chromium intake on the control of type two diabetes mellitus. Patients with uncontrolled diabetes were randomly assigned into two groups. One group received a chromium supplement (200 mcg, BID) in addition to their regular diabetes medication regimen, while the other group relied exclusively on the standard drug treatment. The inclusion criteria for this study included patients diagnosed with uncontrolled type two diabetes mellitus. On the other hand, the exclusion criteria comprised individuals who declined participation, failed to return for follow-up visits, had serum creatinine concentration exceeding 2.0 mg/dL at baseline, reported a history of pancreatitis, recently underwent significant abdominal surgery, were pregnant or intended to become pregnant during the study, or had polycystic ovarian syndrome or irregular menses. The study extended over a three-month follow-up period during which fasting blood sugar, HbA1c levels, and lipid profiles were measured for both groups, facilitating subsequent comparisons. The study was conducted for six months at the Aldiwanyia Teaching Hospital/Diabetes Center in Iraq.